Recent Advances in the Rational Drug Design Based on Multi-target Ligands

Author(s): Ting Yang, Xin Sui, Bing Yu, Youqing Shen, Hailin Cong*

Journal Name: Current Medicinal Chemistry

Volume 27 , Issue 28 , 2020

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Multi-target drugs have gained considerable attention in the last decade owing to their advantages in the treatment of complex diseases and health conditions linked to drug resistance. Single-target drugs, although highly selective, may not necessarily have better efficacy or fewer side effects. Therefore, more attention is being paid to developing drugs that work on multiple targets at the same time, but developing such drugs is a huge challenge for medicinal chemists. Each target must have sufficient activity and have sufficiently characterized pharmacokinetic parameters. Multi-target drugs, which have long been known and effectively used in clinical practice, are briefly discussed in the present article. In addition, in this review, we will discuss the possible applications of multi-target ligands to guide the repositioning of prospective drugs.

Keywords: Multitarget drugs, Alzheimer's disease, Parkinson's disease, cancer, neglected tropical diseases, pharmacokinetic parameters.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [4720 - 4740]
Pages: 21
DOI: 10.2174/0929867327666200102120652
Price: $65

Article Metrics

PDF: 30